ID Q9BY69_HUMAN Unreviewed; 489 AA. AC Q9BY69; DT 01-JUN-2001, integrated into UniProtKB/TrEMBL. DT 01-JUN-2001, sequence version 1. DT 24-JAN-2024, entry version 105. DE SubName: Full=Interferon-gamma receptor {ECO:0000313|EMBL:AAK30623.1}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000313|EMBL:AAK30623.1}; RN [1] {ECO:0000313|EMBL:AAK30623.1} RP NUCLEOTIDE SEQUENCE. RC TISSUE=Blood {ECO:0000313|EMBL:AAK30623.1}; RX PubMed=11139207; DOI=10.1128/CDLI.8.1.133-137.2001; RA Allende L.M., Lopez-Goyanes A., Paz-Artal E., Corell A., Garcia-Perez M.A., RA Varela P., Scarpellini A., Negreira S., Palenque E., Arnaiz-Villena A.; RT "A point mutation in a domain of gamma interferon receptor 1 provokes RT severe immunodeficiency."; RL Clin. Diagn. Lab. Immunol. 8:133-137(2001). CC -!- SIMILARITY: Belongs to the type II cytokine receptor family. CC {ECO:0000256|ARBA:ARBA00005399}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF056979; AAK30623.1; -; mRNA. DR AlphaFoldDB; Q9BY69; -. DR PeptideAtlas; Q9BY69; -. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW. DR GO; GO:0019955; F:cytokine binding; IEA:InterPro. DR GO; GO:0004896; F:cytokine receptor activity; IEA:InterPro. DR GO; GO:0060333; P:type II interferon-mediated signaling pathway; IEA:InterPro. DR Gene3D; 2.60.40.10; Immunoglobulins; 2. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR021126; IFN_gamma_rc_D2_pox/mammal. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR008355; Interferon_gamma_rcpt_asu. DR PANTHER; PTHR20859:SF5; INTERFERON GAMMA RECEPTOR 1; 1. DR PANTHER; PTHR20859; INTERFERON/INTERLEUKIN RECEPTOR; 1. DR Pfam; PF07140; IFNGR1_D2; 1. DR Pfam; PF20634; IFNGR1_transm; 1. DR Pfam; PF01108; Tissue_fac; 1. DR PRINTS; PR01777; INTERFERONGR. DR SUPFAM; SSF49265; Fibronectin type III; 2. PE 2: Evidence at transcript level; KW Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:AAK30623.1}; KW Signal {ECO:0000256|SAM:SignalP}; Transmembrane {ECO:0000256|SAM:Phobius}; KW Transmembrane helix {ECO:0000256|SAM:Phobius}. FT SIGNAL 1..17 FT /evidence="ECO:0000256|SAM:SignalP" FT CHAIN 18..489 FT /evidence="ECO:0000256|SAM:SignalP" FT /id="PRO_5004327335" FT TRANSMEM 247..270 FT /note="Helical" FT /evidence="ECO:0000256|SAM:Phobius" FT DOMAIN 21..112 FT /note="Fibronectin type-III" FT /evidence="ECO:0000259|Pfam:PF01108" FT DOMAIN 132..240 FT /note="Interferon gamma receptor D2" FT /evidence="ECO:0000259|Pfam:PF07140" FT REGION 329..437 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 373..401 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 414..433 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" SQ SEQUENCE 489 AA; 54362 MW; 8BF38D9AA34FC30A CRC64; MALLFLLPLV MQGVSRAEMG TADLGPSSVP TPTNVTIESY NMNPIVYWEY QIMPQVPVFT VEGKNYGVKN SEWIDACINI SHHYCNISDH VGDPSNSLWV RVKARVGQKE SAYAKSEEFA VCRDGKIGPP KLDIRKEEKQ IMIDIFHPSV FVNGDEQEVD YDPETTCYIR VYNVYVRMNG SEIQYKILTQ KEDDCDEIQC QLAIPVSSLN SQYCVSAEGV LHVWGVTTEK SKEVCITIFN SSIKGSLWIP VVAALLLFLV LSLVFICFYI KKINPLKEKS IILPKSLISV VRSATLETKP ESKYVSLITS YQPFSLEKEV VCEEPLSPAT VPGMHTEDNP GKVEHTEELS SITEVVTTEE NIPDVVPGSH LTPIERESSS PLSSNQSEPG SIALNSYHSR NCSESDHSRN GFDTDSSCLE SHSSLSDSEF PPNNKGEIKT EGQELITVIK APTSFGYDKP HVLVDLLVDD SGKESLIGYR PTEDSKEFS //